History of asthma in Canada

References

• Boulet L-P, Batemen ED, Brusselle G, et al. Global Initiative for Asthma, Global strategy for asthma management and prevention. 2019. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Published June 2019. Accessed October 12, 2022.
   Google Scholar
• Manfreda J, Becker AB, Wang PZ, Roos LL, Anthonisen NR. Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest. 1993;103(1):151–157. doi:10.1378/chest.103.1.151.
   Google Scholar
• The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet. 1998;351(9111):1225–1232.
   Google Scholar
• Habbick BF, Pizzichini MM, Taylor B, Rennie D, Senthilselvan A, Sears MR. Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ. 1999;160(13):1824–1828.
   Google Scholar
• Asthma Society of Canada. Asthma Facts and Statistics. https://greenhealthcare.ca/wp-content/uploads/2016/10/asthmastats.pdf. Published October 2016. Accessed October 12, 2022.
   Google Scholar
• Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada, 1996-2005; a population study. Am J Epidemiol. 2010;172(6):728–736. doi:10.1093/aje/kwq189.
   Google Scholar
• Bosonea A-M, Sharpe H, Wang T, et al. Developments in asthma incidence and prevalence in Alberta between 1995 and 2015. Allergy Asthma Clin Immunol. 2020;16:87. doi:10.1186/s13223-020-00485-3.
   Google Scholar
• Elfein J. Asthma prevalence in Canada by province. https://www.statista.com/statistics/881468/asthma-prevalence-canada-by-province/. Published June 17, 2018. Accessed October 12, 2022.
   Google Scholar
• Statistics Canada. Asthma, by age group. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009608. Published August 26, 2022. Accessed October 12, 2022.
   Google Scholar
• Dales RE, Raizenne M, el-Saadany S, Brook J, Burnett R. Prevalence of childhood asthma across Canada. Int J Epidemiol. 1994;23(4):775–781. doi:10.1093/ije/23.4.775.
   Google Scholar
• Senthilselvan A. Prevalence of physician-diagnosed asthma in Saskatchewan, 1981 to 1990. Chest. 1998;114(2):388–392. doi:10.1378/chest.114.2.388.
   Google Scholar
• Wang H-Y, Pizzichini MMM, Becker AB, et al. Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities. Pediatr Allergy Immunol. 2010;21(5):867–877. doi:10.1111/j.1399-3038.2010.01064.x.
   Google Scholar
• Government of Canada. Asthma and Chronic Obstructive Pulmonary Disease (COPD) in Canada, 2018. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/asthma-chronic-obstructive-pulmonary-disease-canada-2018.html. Updated December 9, 2019. Accessed October 12, 2022.
   Google Scholar
• Government of Canada. Data Blog, Asthma in Canada. https://health-infobase.canada.ca/datalab/asthma-blog.html. Published May 5, 2018. Accessed October 12, 2022.
   Google Scholar
• Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Asthma and Chronic Obstructive Pulmonary Disease in Canada, 2018. https:/www.canada.ca/content/dam/phac-aspc/documents/services/publications/diseases-conditions/asthma-chronic-obstructive-pulmonary-disease-canada-2018/pub-eng.pdf. Published March 2018. Accessed October 12, 2022.
   Google Scholar
• To T, Stanojevic S, Feldman R. et al. Is asthma a vanishing disease? A study to forecast the burden of asthma in 2022. BMC Public Health. 2013;13:254. doi:10.1186/1471-2458-13-254.
   Google Scholar
• Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–1260. doi:10.1136/bmj.299.6710.1259.
   Google Scholar
• Ernst P, Cormier Y. Relative scarcity of asthma and atopy among rural adolescents raised on a farm. Am J Respir Crit Care Med. 2000;161(5):1563–1566. doi:10.1164/ajrccm.161.5.9908119.
   Google Scholar
• von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med. 1994;149(2):358–364. doi:10.1164/ajrccm.149.2.8306030.
   Google Scholar
• von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet. 1998;351(9106):862–866. doi:10.1016/S0140-6736(97)10100-3.
   Google Scholar
• Hogg RS, Schechter MT, Montaner JSG, Hogg JC. Asthma mortality in Canada, 1946 to 1990. Can Respir J. 1995;2(1):61–66. doi:10.1155/1995/921501.
   Google Scholar
• Collins-Williams C. The prognosis of asthma in children. Can Med Assoc J. 1960;82(1):33–37.
   Google Scholar
• Mao Y, Semenciw R, Morrison H, MacWilliam L, Davies J, Wigle D. Increased rates of illness and death from asthma in Canada. CMAJ. 1987;137(7):620–624.
   Google Scholar
• Boulet LP, Milot J, Beaupré A. [The mortality associated with asthma in Québec 1975-1985]. Union Med Can. 1989;118(4):150–157.
   Google Scholar
• Bates DV, Baker-Anderson M. Asthma morality and morbidity in Canada. J Allergy Clin Immunol. 1987;80(3):395–397. doi:10.1016/0091-6749(87)90057-1.
   Google Scholar
• To T, Simatovic J, Zhu J, et al. Asthma deaths in a large provincial health system. A 10-year population-based study. Ann Am Thorac Soc. 2014;11(8):1210–1217. doi:10.1513/AnnalsATS.201404-138OC.
   Google Scholar
• World Health Organization. World Health Rankings; Asthma in Canada. https://www.worldlifeexpectancy.com/canada-asthma. Published 2020. Accessed October 12, 2022.
   Google Scholar
• Little A. Mortality from bronchial asthma. Can Med Assoc J. 1969;100(10):485–487.
   Google Scholar
• Sly RM, O'Donnell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol. 1997;78(4):347–354. doi:10.1016/S1081-1206(10)63195-X.
   Google Scholar
• Centers for Disease Control and Prevention. Asthma as the Underlying Cause of Death. https://www.cdc.gov/asthma/asthma_stats/asthma_underlying_death.html. Updated April 24, 2018. Accessed October 12, 2022.
   Google Scholar
• World Health Organization. World Health Rankings; Asthma in the United States. https://www.worldlifeexpectancy.com/united-states-asthma. Published 2020. Accessed October 12, 2022.
   Google Scholar
• Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994;149(3 Pt 1):604–610. doi:10.1164/ajrccm.149.3.8118625.
   Google Scholar
• Cockcroft DW, Swystun VA, Bhagat R. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med. 1995;152(5):1485–1489. doi:10.1164/ajrccm.152.5.7582281.
   Google Scholar
• Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993;342(8875):833–837. doi:10.1016/0140-6736(93)92695-P.
   Google Scholar
• Stolley PD, Schinnar R. Association between asthma mortality and isoproterenol aerosols: a review. Prev Med. 1978;7(4):519–538. doi:10.1016/0091-7435(78)90265-7.
   Google Scholar
• Sears MR. Short-acting beta-agonist research: a perspective. Can Respir J. 2001;8(5):349–355. doi:10.1155/2001/987151.
   Google Scholar
• Osler W, ed. The Principles and Practise of Medicine: Designed for the Use of Practitioners and Students of Medicine. 3rd ed. New York: D. Appleton and Company, 1898. 628–632.
   Google Scholar
• Osler W, ed. Osler’s modern medicine, its theory and practice., In Original Contributions by American and Foreign Authors. Vol. III. Philadelphia and New York: Lea Brothers & Co., 1907. 720–722.
   Google Scholar
• Rudolf RD. Res Judicatae: Bronchial asthma. Can Med Assoc J. 1911;1(11):1102–1106.
   Google Scholar
• Detweiler HK. An address on asthma: Its diagnosis and treatment. Can Med Assoc J. 1927;17(7):783–787.
   Google Scholar
• Heaton TG. Asthma and hay fever. Can Med Assoc J. 1933;28(3):313–316.
   Google Scholar
• Detweiler HK. An address on asthma. Can Med Assoc J. 1939;41(5):465–468.
   Google Scholar
• Detweiler HK. Management of asthma. Can Med Assoc J. 1947;56(4):392–395.
   Google Scholar
• Bennett MR. One hundred years of adrenaline: the discovery of autoreceptors. Clin Auton Res. 1999;9(3):145–159. doi:10.1007/BF02281628.
   Google Scholar
• Macdermot HE. The use of ephedrine in bronchial asthma. Can Med Assoc J. 1926;16(4):422–423.
   Google Scholar
• McPhedran H. Comments on ephedrine and its uses. Can Med Assoc J. 1928;18(3):295–297.
   Google Scholar
• Rose B, Pare JAP, Pump K, Stanford RL. ACTH in asthma. Can Med Assoc J. 1950;62(1):6–9.
   Google Scholar
• Mitchell HS, Cameron G. Cortisone in asthma. Can Med Assoc J. 1952;66(4):313–316.
   Google Scholar
• Gregoire C, Rose B. Clinical use of prednisone and prednisolone in allergic states and collagen diseases. Can Med Assoc J. 1957;77(9):833–839.
   Google Scholar
• Stein SW, Thiel CG. The history of therapeutic aerosols: A chronological review. J Aerosol Med Pulm Drug Deliv. 2017;30(1):20–41. doi:10.1089/jamp.2016.1297.
   Google Scholar
• Woolf CR. Drugs in the treatment of asthma. Can Med Assoc J. 1964;91(2):77–78.
   Google Scholar
• Chan-Yeung M, Morton J, Grzybowski S. A double-blind trial of disodium cromoglycate (Intal) in the treatment of bronchial asthma. Can Med Assoc J. 1971;105(8):827–831.
   Google Scholar
• Schonell M, Chan-Yeung M, McLean L. Salbutamol—an effective bronchodilator. Can Med Assoc J. 1972;106(4):339–341.
   Google Scholar
• Kerigan AT, Pugsley SO, Cockcroft DW, Hargreave FE. Substitution of inhaled beclomethasone dipropionate for ingested prednisone in steroid-dependent asthmatics. Can Med Assoc J. 1977;116(8):867–871.
   Google Scholar
• Toogood JH, Lefcoe NM. Dexamethasone aerosol for the treatment of “steroid dependent” chronic bronchial asthmatic patients. J Allergy. 1965;36(4):321–332. doi:10.1016/0021-8707(65)90039-0.
   Google Scholar
• Boulet LP, Chapman KR, Coté J, et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med. 1997;155(6):1835–1840. doi:10.1164/ajrccm.155.6.9196083.
   Google Scholar
• Nair P, Pizzichini MMM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360(10):985–993. doi:10.1056/NEJMoa0805435.
   Google Scholar
• Nair P, Bardin P, Humbert M, et al. Efficacy of intravenous reslizumab in oral corticosteroid-dependent asthma. J Allergy Clin Immunol Pract. 2020;8(2):555–564. doi:10.1016/j.jaip.2019.09.036.
   Google Scholar
• Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol. 2013;132(5):1086–1096.e5. doi:10.1016/j.jaci.2013.05.020.
   Google Scholar
• Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475–2485. doi:10.1056/NEJMoa1804093.
   Google Scholar
• Gauvreau GM, O'Byrne PM, Boulet L-P, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370(22):2102–2110. doi:10.1056/NEJMoa1402895.
   Google Scholar
• Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990;85(6):1098–1111. doi:10.1016/0091-6749(90)90056-a.
   Google Scholar
• Woolcock A, Rubinfeld AR, Seale JP, et al. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989;151(11-12):650–653. doi:10.5694/j.1326-5377.1989.tb139640.x.
   Google Scholar
• British Thoracic Society. Guidelines for management of asthma in adults: I—Chronic persistent asthma. Statement by the British thoracic society, research unit of the royal college of physicians of London, King’s fund centre, national asthma campaign. BMJ. 1990;301(6753):651–653.
   Google Scholar
• National Heart, Lung, and Blood Institute. National asthma education program. Expert panel report. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol. 1991;88(3 Pt 2):425–534.
   Google Scholar
• Boulet L-P, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM. The global initiative for asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598. doi:10.1183/13993003.00598-2019.
   Google Scholar
• Ernst P, FitzGerald JM, Spier S. Canadian asthma consensus conference: Summary of recommendations. Can Respir J. 1996;3:101–114.
   Google Scholar
• Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Canadian asthma consensus group. CMAJ. 1999;161(11 Suppl):S1–S61.
   Google Scholar
• O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50(3):1701103. doi:10.1183/13993003.01103-2017.
   Google Scholar
• Yang CL, Hicks EA, Mitchell P, et al. 2021 Canadian thoracic society guideline – A focused update on the management of very mild and mild asthma. Can J Respir Crit Care Sleep Med. 2021;5(4):205–245. doi:10.1080/24745332.2021.1877043.
   Google Scholar
• Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7(3):235–243. doi:10.1111/j.1365-2222.1977.tb01448.x.
   Google Scholar
• Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161(1):309–329.
   Google Scholar
• Coates AL, Wanger J, Cockcroft DW, and the bronchoprovocation testing task force, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526. doi:10.1183/13993003.01526-2016.
   Google Scholar
• Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25–29. doi:10.1136/thx.47.1.25.
   Google Scholar
• Dolovich M, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest. 1983;84(1):36–41. doi:10.1378/chest.84.1.36.
   Google Scholar
• ,Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83. doi:10.1136/thx.47.2.76.
   Google Scholar